Cholangitis
MONDO:0004789An acute or chronic inflammatory process affecting the biliary tract.
Also known as: biliary tract infection, biliary tree inflammation, cholangitis, inflammation of biliary tree
142 clinical trials for this condition and its sub-types, 17 tagged with Cholangitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cholangitis
-
Cholecystitis 35 trials · 65 incl. sub-types
4 sub-types
- Acute cholecystitis 35 trials
- Acalculous cholecystitis 0 trials
- Emphysematous cholecystitis 0 trials
- Xanthogranulomatous cholecystitis 0 trials
-
Sclerosing cholangitis 3 trials · 57 incl. sub-types
5 sub-types
- Primary sclerosing cholangitis 54 trials Sub-types →
- Secondary sclerosing cholangitis 2 trials
- IgG4-related sclerosing cholangitis 0 trials
- Isolated neonatal sclerosing cholangitis 0 trials
- Neonatal ichthyosis-sclerosing cholangitis syndrome 0 trials
-
Acute cholangitis 7 trials · 42 incl. sub-types
1 sub-type
- Acute cholecystitis 35 trials
-
Autoimmune cholangitis 1 trial
-
Ascending cholangitis 0 trials
-
Chronic cholangitis 0 trials
-
Pericholangitis 0 trials
-
Suppurative cholangitis 0 trials
Most studied deeper sub-types
-
Can a new drug outperform standard care for a rare liver disease in teens?
Disease control CancelledThis phase 2 trial is testing whether an experimental drug called HTD1801 can improve liver health in adolescents with primary sclerosing cholangitis (PSC), a rare disease that damages the bile ducts. Participants will receive either HTD1801 or the standard treatment, ursodeoxych…
Phase 2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could ditching gluten ease two tough gut diseases?
Disease control OngoingThis study looks at whether a gluten-free diet can help people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). Researchers will track changes in symptoms, gut bacteria, and lab results in 60 adults over time. The goal is to see if avoiding gluten c…
Sponsor: Institute for Clinical and Experimental Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New pill aims to stop the relentless itch of a rare liver disease
Symptom relief OngoingThis study tests an experimental drug called volixibat for people with primary biliary cholangitis (PBC) who suffer from severe itching. The trial will involve 260 adults and compare volixibat against a placebo to see if it safely reduces itch severity and improves quality of lif…
Phase 2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC